WhoHoldsbeta
StocksFundsHow it works
WhoHolds

Reverse holdings lookup for Indian markets. Paste a stock, see every mutual fund and ETF that holds it — with weight, value, and trend.

ExploreAll stocksAll fundsCompare brokersHow it works
Coverage451 funds1003 stocks10 fund houses
LegalDisclaimerPrivacyTermsRefund policyContact

Data sourced from public AMC monthly portfolio disclosures and the AMFI scheme master. Portfolios as on: Aditya Birla SL MF (Apr 2026) · Axis MF (—) · DSP MF (Apr 2026) · HDFC MF (Apr 2026) · ICICI Pru MF (Apr 2026) · Kotak MF (—) · Mirae Asset MF (—) · Nippon India MF (Jul 2025) · SBI MF (Apr 2026) · UTI MF (—). Holdings are ISIN-verified equity positions. For information only — not investment advice.

© 2026 WhoHolds · Built India-first at $0 fixed cost.

Search
Pharmaceuticals & BiotechnologyINE031B01049

Ajanta Pharma

Held by 44 funds across 9 fund houses in our coverage.

Coverage: 10 of India's largest fund houses — more added monthly.

Held by
44 funds
Fund houses
9
Total value held
₹3,522 Cr
Highest weight
25.23%
exposure

Who holds Ajanta Pharma?

#MoM
1UMexposureUTI MF•Equity (Diversified)
25.23%
—₹1,111 Cr39.37 L
2ABAditya Birla Sun Life Pharma & Healthcare FundAditya Birla SL MF•Sectoral / Thematic
4.05%
—₹36.50 Cr1.29 L
3NINippon India Pharma FundNippon India MF•Sectoral / Thematic
3.01%
—₹214.50 Cr9.68 L
4KMKotak Healthcare FundKotak MF•Sectoral / Thematic
2.39%
—₹11.86 Cr42.0K
5SMSBI Healthcare Opportunities FundSBI MF•Sectoral / Thematic
1.96%
—₹84.68 Cr3.00 L
6KMKotak Consumption FundKotak MF•Sectoral / Thematic
1.91%
—₹32.18 Cr1.14 L
7SMSBI Quality FundSBI MF•Smart-Beta / Factor
1.87%
—₹43.19 Cr1.53 L
8KMKotak Small Cap FundKotak MF•Small Cap
1.86%
—₹323.17 Cr11.45 L
9ABAditya Birla Sun Life Midcap FundAditya Birla SL MF•Mid Cap
1.82%
—₹114.68 Cr4.06 L
10ABAditya Birla Sun Life Large & Mid Cap FundAditya Birla SL MF•Large & Mid Cap
1.76%
—₹99.31 Cr3.52 L
11ABAditya Birla Sun Life Retirement Fund - The 30S PlanAditya Birla SL MF•Solution-Oriented
1.73%
—₹7.48 Cr26.5K
12ABAditya Birla Sun Life Manufacturing Equity FundAditya Birla SL MF•Sectoral / Thematic
1.71%
—₹19.76 Cr70.0K
13DMNifty Midcap 150 Q50DSP MF•Mid Cap
1.58%
—₹7.06 Cr25.0K
14DMMidcap 150 Quality 50 ETFDSP MF•ETF
1.58%
—₹1.51 Cr5.3K
15ABAditya Birla Sun Life Business Cycle FundAditya Birla SL MF•Sectoral / Thematic
1.58%
—₹26.61 Cr94.3K
16IPPharmdexICICI Pru MF•Equity (Diversified)
1.40%
—₹1.59 Cr5.6K
17KMKotak Dividend Yield FundKotak MF•Dividend Yield
1.17%
—₹2.65 Cr9.4K
18ABAditya Birla Sun Life Balanced Advantage FundAditya Birla SL MF•Hybrid
0.95%
—₹86.84 Cr3.08 L
19KMKotak Contra FundKotak MF•Contra
0.94%
—₹48.33 Cr1.71 L
20HMHdfclargefHDFC MF•Equity (Diversified)
0.90%
—₹253.26 Cr8.97 L
21NINippon India Small Cap FundNippon India MF•Small Cap
0.79%
—₹398.94 Cr18.01 L
22SMSBI Flexicap FundSBI MF•Flexi Cap
0.54%
—₹121.38 Cr4.30 L
23NINippon India Vision FundNippon India MF•Equity (Diversified)
0.49%
—₹22.15 Cr1.00 L
24KMKotak Large & Midcap FundKotak MF•Large & Mid Cap
0.47%
—₹141.14 Cr5.00 L
25NINippon India Multi Cap FundNippon India MF•Multi Cap
0.46%
—₹139.34 Cr6.29 L
26HMHdfcmulcapHDFC MF•Equity (Diversified)
0.46%
—₹89.06 Cr3.16 L
27NINippon India ETF Nifty Midcap 150Nippon India MF•ETF
0.34%
—₹4.64 Cr21.0K
28NINippon India Nifty Midcap 150 Index FundNippon India MF•Index Fund
0.34%
—₹4.28 Cr19.3K
29KMKotak Nifty Midcap 150 Index FundKotak MF•Index Fund
0.31%
—₹9.43 L334
30IPMd150EtfICICI Pru MF•ETF
0.30%
—₹2.10 Cr7.4K
31IPMid150ICICI Pru MF•Equity (Diversified)
0.30%
—₹3.14 Cr11.1K
32ABAditya Birla Sun Life Nifty Midcap 150 Index FundAditya Birla SL MF•Index Fund
0.30%
—₹1.35 Cr4.8K
33SMSBI Nifty Midcap 150 Index FundSBI MF•Index Fund
0.30%
—₹3.17 Cr11.2K
34DMNifty Midcap 150 IndexDSP MF•Index Fund
0.30%
—₹3.95 L140
35KMKotak Nifty Midcap 150 ETFKotak MF•ETF
0.30%
—₹3.58 L127
36SMSBI Nifty Midcap150 ETFSBI MF•ETF
0.30%
—₹3.19 L113
37DMNifty Midcap 150 ETFDSP MF•ETF
0.30%
—₹1.86 L66
38NINippon India Growth FundNippon India MF•Equity (Diversified)
0.24%
—₹63.91 Cr2.88 L
39IPN250DexICICI Pru MF•Equity (Diversified)
0.15%
—₹40.31 L1.4K
40IPSpbseetfICICI Pru MF•ETF
0.06%
—₹22.34 L791
41IPIndex500ICICI Pru MF•Index Fund
0.06%
—₹5.22 L185
42SMSBI Nifty 500 Index FundSBI MF•Index Fund
0.06%
—₹46.60 L1.7K
43DMNifty 500 IndexDSP MF•Index Fund
0.06%
—₹0.82 L29
44AMAxis Nifty 500 Index FundAxis MF•Index Fund
—
—₹18.49 L655

By fund type

44funds
  • Equity (Diversified)44%
  • Small Cap21%
  • Sectoral / Thematic12%
  • Large & Mid Cap7%
  • Multi Cap4%
  • Mid Cap3%
  • Flexi Cap3%
  • Other6%

By fund house

  • UTI MF₹1,111 Cr1
  • Nippon India MF₹848 Cr7
  • Kotak MF₹559 Cr8
  • Aditya Birla SL MF₹393 Cr8
  • HDFC MF₹342 Cr2
  • SBI MF₹253 Cr6
  • DSP MF₹9 Cr5
  • ICICI Pru MF₹8 Cr6
  • Axis MF₹0 Cr1

Funds here also hold

Persistent Systems Limited
IT - Software
93
funds
Fortis Healthcare Limited
Healthcare Services
95
funds
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
60
funds
Bharat Forge Limited
Auto Components
90
funds
AU Small Finance Bank Limited
Banks
91
funds
Bank of Maharashtra
Banks
50
funds

Ajanta Pharma holdings — FAQ

How many mutual funds hold Ajanta Pharma?
44 mutual funds and ETFs in WhoHolds' coverage hold Ajanta Pharma Ltd, spread across 9 fund houses.
Which fund holds the most Ajanta Pharma?
exposure (UTI MF) gives it the highest weight, at 25.23% of the fund's portfolio.
What is the total value of Ajanta Pharma held by these funds?
Together these funds hold about ₹3,522 Cr worth of Ajanta Pharma (ISIN-verified equity positions).
As of when is this Ajanta Pharma holdings data?
Portfolios as on UTI MF — · Aditya Birla SL MF Apr 2026 · Nippon India MF Jul 2025 · Kotak MF — · SBI MF Apr 2026 · DSP MF Apr 2026 · ICICI Pru MF Apr 2026 · HDFC MF Apr 2026 · Axis MF —, taken from each AMC's public monthly portfolio disclosure. This is information only, not investment advice.

Portfolios as on: UTI MF — · Aditya Birla SL MF Apr 2026 · Nippon India MF Jul 2025 · Kotak MF — · SBI MF Apr 2026 · DSP MF Apr 2026 · ICICI Pru MF Apr 2026 · HDFC MF Apr 2026 · Axis MF —. ISIN-verified equity positions from public AMC disclosures. Not investment advice.